Commentary: The Schizophrenia Prodrome: A High-Risk Concept

Schizophrenia Bulletin

Volumn 29, Issue 4, 2003, Pages 859-865

  Yung, Alison R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CONCEPT FORMATION; CONFERENCE PAPER; CRISIS INTERVENTION; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; NEUROCHEMISTRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREPSYCHOSIS; PRIORITY JOURNAL; PRODROMAL SCHIZOPHRENIA; PSYCHOSIS; RISK ASSESSMENT; SCHIZOPHRENIA; SYNDROME;

EID: 0842278749     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a007052     Document Type: Conference Paper

References (47)

1. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., revised. Washington, DC: APA, 1987.
2. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: APA, 1994.
3. Asarnow, J.R. Children at risk for schizophrenia: converging lines of evidence. Schizophrenia Bulletin, 14(4):613-631, 1988.
4. Cannon, T.D.; van Erp, T.G.M.; Bearden, C.E.; Loewy, R.; Thompson, P.; Toga, A.W.; Huttunen, M.O.; Keshavan, M.; Seidman, L.J.; and Tsuang, M.T. Early and late neurodevelopmental influences in the prodrome to schizophrenia: Contributions of genes, environment, and their interactions. Schizophrenia Bulletin, 29(4):653-669, 2003.
5. Chapman, L.J., and Chapman, J.P. The search for symptoms predictive of schizophrenia. Schizophrenia Bulletin, 13(3):497-503, 1987.
6. Corcoran, C.; Walker, E.; Huot, R.; Mittal, V.; Tessner, K.; and Kestler, L. The stress cascade and schizophrenia: Etiology and onset. Schizophrenia Bulletin, 29(4):671-692, 2003.
7. Comblatt, B.; Obuchowski, M.; Schnur, D.; and O'Brien, J.D. Hillside study of risk and early detection in schizophrenia. British Journal of Psychiatry, 172(Suppl 33):26-32, 1998.
8. Eaton, W.W.; Romanoski, A.; Anthony, J.C.; and Nestadt, G. Screening for psychosis in the general population with a self-report interview. Journal of Nervous & Mental Disease, 179(11):689-693, 1991.
9. Erlenmeyer-Kimling, L.; Rock, D.; Roberts, S.A.; Janal, M.; Kestenbaum, C.; Cornblatt, B.; Adamo, U.H.; and Gottesman, I.I. Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: The New York High-Risk Project. American Journal of Psychiatry, 157(9):1416-1422, 2000.
10. Falloon, I.R.H. Early intervention for first episodes of schizophrenia: a preliminary exploration. Psychiatry, 55:4-15, 1992.
11. Falloon, I.R.H. General practice recruitment for people at risk of schizophrenia: The Buckingham experience. Australian & New Zealand Journal of Psychiatry, 34(Suppl):131-136, 2000.
12. French, P.; Morrison, A.P.; Walford, L.; Knight, A.; and Bentall, R.P. Cognitive therapy for preventing transition to psychosis in high risk individuals: A case series. Behavioural & Cognitive Psychotherapy, 31(1):53-67, 2003.
13. Hafner, H.; Maurer, K.; Loffler, W.; and Riecher, R.A. The influence of age and sex on the onset and early course of schizophrenia. British Journal of Psychiatry, 162(80):80-86, 1993.
14. Hafner, H.; Riecher, R.A.; Hambrecht, M.; Maurer, K.; Meissner, S.; Schmidtke, A.; Fatkenheuer, B.; Loffler, W.; and Van Der Heiden, W. IRAOS: An instrument for the assessment of onset and early course of schizophrenia. Schizophrenia Research, 6(3):209-223, 1992.
15. Heinssen, R.K.; Cuthbert, B.N.; Breiling, J.; Colpe, L.; and Dolan-Sewell, R. Overcoming barriers to research in early serious mental illness: Issues for future collaboration. Schizophrenia Bulletin, 29(4):737-745, 2003.
16. Heinssen, R.K.; Perkins, D.O.; Appelbaum, P.S.; and Fenton, W.S. Informed consent in early psychosis research: National Institute of Mental Health Workshop, November 15, 2000. Schizophrenia Bulletin, 27(4):571-584, 2001.
17. Kane, J.M.; Krystal, J.; and Correll, C.U. Treatment models and designs for intervention research during the psychotic prodrome. Schizophrenia Bulletin, 29(4):747-756, 2003.
18. Keshavan, M.S.; Haas, G.; Miewald, J.; Montrose, D.M.; Reddy, R.; Schooler, N.R.; and Sweeney, J.A. Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophrenia Bulletin, 29(4):757-769, 2003.
19. Krabbendam, L.; Janssen, I.; Bak, M.; Bijl, R.V.; de Graaf, R.; and van Os, J. Neuroticism and low self-esteem as risk factors for psychosis. Social Psychiatry & Psychiatric Epidemiology, 37(1):1-6, 2002.
20. Lencz, T.; Smith, C.W.; Auther, A.M.; Correll, C.U.; and Comblatt, B.A. The assessment of "prodromal schizophrenia": Unresolved issues and future directions. Schizophrenia Bulletin, 29(4):717-728, 2003.
21. Maier, W.; Comblatt, B.A.; and Merikangas, K. Transition to schizophrenia and related disorders: Toward a taxonomy of risk. Schizophrenia Bulletin, 29(4):693-701, 2003.
22. Manji, H.K.; Moore, G.J.; and Chen, G. Lithium at 50: Have the neuroprotective effects of this unique cation been overlooked? Biological Psychiatry, 46(7):929-940, 1999.
23. McGlashan, T.H.; Zipursky, R.B.; Perkins, D.; Addington, J.; Miller, T.J.; Woods, S.W.; Hawkins, K.A.; Hoffman, R.; Lindborg, S.; Tohen, M.; and Breier, A. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophrenia Research, 61(1):7-18, 2003.
24. McGorry, P.D.; Edwards, J.; Mihalopoulos, C.; Harrigan, S.M.; and Jackson, H.J. EPPIC: An evolving system of early detection and optimal management. Schizophrenia Bulletin, 22(2):305-326, 1996.
25. McGorry, P.D., and Singh, B.S. Schizophrenia: risk and possibility. In: Raphael, B., and Burrows, G.D., eds. Handbook of Preventive Psychiatry. Amsterdam, The Netherlands: Elsevier, 1995. pp. 492-514.
26. McGorry, P.D., and Yung, A.R. Early intervention in psychosis: An overdue reform. Australian & New Zealand Journal of Psychiatry, 37:393-398, 2003.
27. McGorry, P.D.; Yung, A.R.; and Phillips, L.J. The "close-in" or ultra high-risk model: A safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophrenia Bulletin, 29(4):771-790, 2003.
28. McGorry, P.D.; Yung, A.R.; Phillips, L.J.; Yuen, H.P.; Francey, S.; Cosgrave, E.M.; Bravin, J.; Adlard, S.; MacDonald, T.; Blair, A.; and Jackson, H. Randomized controlled trial of interventions designed to reduce the risk of progression to first episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry, 59:921-928, 2002.
29. Mednick, S.A.; Parnas, J.; Schulsinger, F.; and Mednick, B. The Copenhagen High-Risk Project, 1962-1986. Schizophrenia Bulletin, 13(3):485-496, 1987.
30. Miller, T.J.; McGlashan, T.H.; Rosen, J.L.; Cadenhead, K.; Ventura, J.; McFarlane, W.; Perkins, D.O.; Pearlson, G.D.; and Woods, S.W. Prodromal assessment with the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: Predictive validity, interrater reliability, and training to reliability. Schizophrenia Bulletin, 29(4):703-715, 2003.
31. Miller, T.J.; Zipursky, R.B.; Perkins, D.; Addington, J.; Woods, S.W.; Hawkins, K.A.; Hoffman, R.; Preda, A.; Epstein, I.; Addington, D.; Lindborg, S. ; Marquez, E.; Tohen, M.; Breier, A.; and McGlashan, T.H. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample. Schizophrenia Research, 61(1):19-30, 2003.
32. Mojtabai, R.; Malaspina, D.; and Susser, E. Concepts of population prevention: Application to schizophrenia. Schizophrenia Bulletin, 29(4):791-801, 2003.
33. Morrison, A.P.; Bentall, R.P.; French, P.; Walford, L.; Kilcommons, A.; Knight, A.; Kreutz, M.; and Lewis, S.W. Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals: Study design and interim analysis of transition rate and psychological risk factors. British Journal of Psychiatry, 181(Suppl43):S78-S84, 2002.
34. Mrazek, P.J., and Haggerty, R.J., eds. Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention Research. Washington, DC: National Academy Press, 1994.
35. Pantelis, C.; Velakoulis, D.; McGorry, P.D.; Wood, S.J.; Suckling, J.; Phillips, L.J.; Yung, A.R.; Bullmore, E.T.; Brewer, W.; Soulsby, B.; Desmond, P.; and McGuire, P.K. Neuroanatomical abnormalities before and after onset of psychosis: A cross-sectional and longitudinal MRI comparison. The Lancet, 361(9354):281-288, 2003.
36. Peters, E.; Day, S.; McKenna, J.; and Orbach, G. Delusional ideation in religious and psychotic populations. British Journal of Clinical Psychology, 38(1):83-96, 1999a.
37. Peters, E.R.; Joseph, S.A.; and Garety, P.A. Measurement of delusional ideation in the normal population: Introducing the PDI (Peters et al. Delusions Inventory). Schizophrenia Bulletin, 25(3):553-576, 1999b.
38. Seidman, L.J.; Pantelis, C.; Keshavan, M.S.; Faraone, S.V.; Goldstein, J.M.; Horton, N.J.; Makris, N.; Falkai, P.; Caviness, V.S.; and Tsuang, M.T. A review and a new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: A magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophrenia Bulletin, 29(4):803-830, 2003.
39. Tien, A.Y. Distributions of hallucinations in the population. Social Psychiatry & Psychiatric Epidemiology, 26(6):287-292, 1991.
40. van Os, J.; Hanssen, M.; Bijl, R.V.; and Ravelli, A. Straus (1969) revisited: A psychosis continuum in the general population? Schizophrenia Research, 45(1-2):11-20, 2000.
41. van Os, J.; Hanssen, M.; Bijl, R.V.; and Vollebergh, W. Prevalence of psychotic disorder and community level of psychotic symptoms: An urban-rural comparison. Archives of General Psychiatry, 58(7):663-668, 2001.
42. Wood, S.J.; Berger, G.; Velakoulis, D.; Phillips, L.J.; McGorry, P.D.; Yung, A.R.; Desmond, P.; and Pantelis, C. Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals. Schizophrenia Bulletin, 29(4):831-843, 2003.
43. Yung, A.R., and McGorry, P.D. The prodromal phase of first episode psychosis: past and current conceptualizations. Schizophrenia Bulletin, 22(2):353-370, 1996.
44. Yung, A.R.; McGorry, P.D.; McFarlane, C.A.; Jackson, H.J.; Patton, G.C.; and Rakker, A. Monitoring and care of young people at incipient risk of psychosis. Schizophrenia Bulletin, 22(2):283-303, 1996.
45. Yung, A.R.; McGorry, P.D.; McFarlane, C.A.; and Patton, G. The PACE Clinic: Development of a clinical service for young people at high risk of psychosis. Australian Psychiatry, 3(5):345-349, 1995.
46. Yung, A.R.; Phillips, L.J.; Yuen, H.P.; Francey, S.M.; McFarlane, C.A.; Hallgren, M.; and McGorry, P.D. Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophrenia Research, 60(1):21-32, 2003.
47. Yung, A.R.; Phillips, L.J.; Yuen, H.P.; and McGorry, P.D. Risk factors for psychosis in an Ultra High Risk group: Psychopathology and clinical features. Schizophrenia Research, in press.